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What is already known on this topic?
 ► The evaluation of interventions for the 
treatment of children with suspected or proven 
severe infection has been hampered by the 
underdevelopment of outcome measures.
 ► The selection of clinical trial outcome measures 
is predominantly led by clinicians and 
researchers rather than by patients and their 
families.
 ► Research is needed to ensure the selection of 
outcomes in trials investigating treatments for 
paediatric severe infection reflects the priorities 
of families.
What this study adds?
 ► Our synthesis showed that in addition to 
survival, parents prioritised short-term outcomes 
including: organ and physiological functioning 
(eg, heart rate, breathing rate and temperature); 
their child looking and/or behaving more 
like their normal self; and length of time on 
treatments or mechanical support.
 ► Longer term prioritised outcomes included 
effects of illness on child health and 
development.
 ► Parents’ prioritisation of outcomes was 
influenced by their experience of their child’s 
illness, survival and the point at which they are 
asked about outcomes of importance in the 
course of their child’s illness.
AbsTrACT
Objective To identify parents’ prioritised outcomes by 
combining qualitative findings from two trial feasibility 
studies of interventions for paediatric suspected severe 
infection.
Design Qualitative synthesis combining parent 
interview data from the Fluids in Shock (FiSh) and Fever 
feasibility studies. Parents had experience of their child 
being admitted to a UK emergency department or 
intensive care unit with a suspected infection.
Participants n=: 85 parents. FiSh study: n=41 parents, 
37 mothers, 4 fathers, 7 were bereaved. Fever study: 
n=44 parents, 33 mothers, 11 fathers, 7 were bereaved.
results In addition to survival, parents prioritised 
short-term outcomes including: organ and physiological 
functioning (eg, heart rate, breathing rate and 
temperature); their child looking and/or behaving more 
like their normal self; and length of time on treatments 
or mechanical support. Longer term prioritised 
outcomes included effects of illness on child health and 
development. We found that parents’ prioritisation of 
outcomes was influenced by their experience of their 
child’s illness, survival and the point at which they are 
asked about outcomes of importance in the course of 
their child’s illness.
Conclusions Findings provide insight into parent 
prioritised outcomes to inform the design of future 
trials investigating treatments for paediatric suspected 
or proven severe infection as well as core outcome set 
development work.
InTrODuCTIOn
Severe infections remain a major cause of mortality 
and morbidity in paediatric clinical care.1 Interna-
tional research prioritisation exercises2–4 highlight 
the need for research to explore which interventions 
may improve patient outcomes for paediatric severe 
infection. However, little knowledge exists about 
which outcomes are most important to parents of 
children treated for severe infection requiring fluid 
resuscitation and/or intensive care admission.5 6 
Despite recognition that patients and the public 
have a legitimate and requisite role in the design 
and conduct of health research, the extent to which 
this occurs is less clear.7 8 Two systematic reviews7 9 
of outcome measures in clinical trials suggest that 
they are predominantly selected by clinicians and 
researchers. Sinha et al9 observed that only 3 out 
of 13 groups who had published on the selection of 
outcomes for paediatric clinical trials had consulted 
parents; none involved children.
To inform the design of two trials involving chil-
dren with suspected severe infection, we used qual-
itative research to explore parents’ views on trial 
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Table 1 Overview of the Fluids in Shock (FiSh) and Fever feasibility study designs
Fish Fever study
Aims To establish the feasibility of conducting a randomised controlled 
trial comparing restrictive fluid bolus therapy (10 mL/kg) with the 
current UK recommended practice (20 mL/kg).
To establish the feasibility of conducting a definitive trial comparing 
temperature thresholds at which staff deliver antipyretic intervention in 
critically ill children with fever due to infection (intervention treat at ≥39.5°C, 
standard care treat at >37.5°C).
Feasibility study elements (1) Qualitative study exploring parent views. (2) Nine-month pilot 
trial with integrated parent and staff perspectives study.
(1) Qualitative study exploring parent and clinician views. (2) Observational 
study of the epidemiology of fever in children with infection in paediatric 
intensive care unit. (3) Four-month pilot trial with integrated parent and staff 
perspectives study.
Pilot trial participants Children (age >37 weeks (corrected gestational age) 
and <16 years) admitted to an emergency department with clinical 
suspicion of infection and signs of shock after receipt of 20 mL/kg 
of bolus fluid.
Children (age >29 days and <16 years) admitted to intensive care with a 
fever (≥37.5°C) in the first 48 hours and suspected infection who require 
mechanical ventilation.
Figure 1 Participant recruitment and sample characteristics by study 
and phase.
acceptability and important treatment outcomes. This paper 
presents combined qualitative findings from the Fluids in Shock 
(FiSh) and Fever studies (see table 1) on parents’ prioritised 
outcomes.
MeThODs
FiSh and Fever studies took place between 2015 and 2018. Both 
began with a qualitative feasibility study, led by the same qual-
itative research team (phase 1). This involved semistructured 
interviews with parents (including bereaved parents) of children 
who had attended UK emergency departments (EDs) or were 
admitted to a paediatric intensive care unit (PICU) with severe 
infection in the previous 3 years. Phase 1 informed the design 
of pilot trials (phase 2; 9-month recruitment period in FiSh and 
4 months in Fever), which had an integrated interview element 
involving parents of randomised patients.
We used previous research10–12 to develop interview topic 
guides to explore parents’ views on trial design and conduct,13 
including outcomes for the proposed definitive trials (see online 
supplementary table S1). To inform discussions with parents 
(phase 1), we conducted a literature review to develop a list 
of outcome measures previously reported in paediatric severe 
infection research.
recruitment and interview conduct
Based on previous studies14 15 we anticipated needing 15–25 
parents for each qualitative study phase (see figure 1). In phase 
1 studies, parents were recruited through postal contact, adver-
tising in EDs and PICUs and online including social media.13 A 
database of FiSh potential participants who consented to contact 
about future studies but had not taken part in an interview in 
FiSh were approached to participate in Fever. In phase 2 studies, 
clinicians provided parents with information and sought consent 
to contact for interviews as part of the FiSh and Fever pilot trial 
consent discussion.
In phase 1, expressions of interest to participate were 
responded to sequentially. Selection of parents for interview 
aimed to ensure variance of recruitment method (eg, social 
media, postal/database invitation and poster advert). The list 
of potential outcomes was emailed to parents to read prior 
to interview. Verbal consent was audio recorded. In phase 2, 
CO, ED or KW contacted parents within 1 month of consent 
or hospital discharge. Selection of parents for interview 
aimed to include all pilot sites and range of parent experi-
ence (eg, consented and declined the trial and trial arm allo-
cation). Consent for audio recording was confirmed. In both 
phases, parents were asked to reflect on their personal expe-
riences to identify important outcomes for future trials (see 
online supplementary table S1). Screening and interviews 
stopped on reaching data saturation (see online S2 box 2 for a 
glossary of terms).16 17
A professional transcription company (Voicescript Ltd, Bristol, 
UK) transcribed verbatim digital audio recordings. Transcripts 
were anonymised and checked for accuracy.
Data analysis and synthesis
Psychologists CO (PhD, female research associate FiSh) and ED 
(PhD, female research associate Fever) led the analysis with assis-
tance and oversight from KW (sociologist). Analysis for each study 
was broadly interpretive, inductive and iterative14 18 as informed 
by the constant comparative approach.19–22 Outcomes were 
identified through direct questioning as well as referred to indi-
rectly by parents during wider interview discussion.
NVivo V.10 software (QSR International Pty Ltd, 
Melbourne, Australia) was used to assist in the organisation 
and coding of data. CO, ED and KW met regularly to discuss 
interpretation and develop the coding framework. To present 
a prioritised list of outcomes for each study phase, we listed 
outcomes in order of how commonly they were discussed by 
parents. Outcomes discussed through direct questioning were 
placed higher in the list than outcomes identified in general 
interview discussions. Lists for FiSh and Fever phases 1 and 2 
were then merged.
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Table 2 Illustrative quotes for the top five prioritised outcomes
Prioritised 
outcome Illustrative quotes from Fish and Fever
Improvement 
in organ and 
physiological 
function
‘The organ dysfunction was a big thing’ (P17, mother, bereaved, 
FiSh phase 1).
‘Probably things like heart rate coming down, blood pressure 
going up, his temperature improving, which it did very quickly’ 
(P41, mother, non-bereaved, FiSh phase 2).
‘It would be things like his vital signs being normal, um, so 
obviously temperature, breathing, heart rate’ (P01, mother, non-
bereaved, Fever phase 1).
‘So it’s taking the measures really that the nurses are looking 
at, like temperature, erm, infection markers, erm, heart rate, 
things like that. You get glued to the screens which have all the 
information on’ (P82, mother, non-bereaved, Fever phase 2).
Looking and 
behaving more like 
normal self
‘When they did wake him up he was alert and he could talk 
to his sister. So you know, as far as I was concerned he was 
actually getting over it, he'd sorted the chest infections, it was 
the secondary one that got him unfortunately’ (P21, mother, 
bereaved, FiSh phase 1).
‘I wanted his […] rash to stop spreading all over his body… 
It was spreading rapidly all over his body and his face was 
swelling. It was the most scariest thing to ever witness’ (P40, 
mother, non-bereaved, FiSh phase 2).
‘The fact that they’re more with it, um more alert. Um, ‘cause 
like with (child name) you know when he’s getting better 
‘cause he’s got a cheeky little smile. Every parent will know in 
themselves when their child is getting better, um, wanting to 
get out, wanting to sit up, you know, having something to eat 
and drink’ (P11, mother, non-bereaved, Fever phase 1).
‘Erm, that he’s, erm, behaving more himself, so he’s maybe 
not, not the same as… not so lethargic, erm, not warm to the 
touch, not clammy, sweaty, and sort of returning to his normal 
behaviours’(P80, mother, non-bereaved, Fever phase 2).
Long-term effects 
(eg, health and 
development)
‘I think developmental sort of outcomes after is quite important, 
you know, whether it’s had a long term effect on them’ (P8, 
mother, non-bereaved, FiSh phase 1).
‘The thing I was most worried about when, um, when we left 
hospital was any long-term effects. Because obviously I mean 
she was less than five weeks old, she’d, she hadn’t stopped 
breathing entirely but she’d, um, she wasn’t taking as much, 
many breaths as she should have done, so I was really worried 
about would there be any long-term development problems 
with her’ (P25, mother, non-bereaved, Fever phase 1).
Length of hospital 
stay
‘Definitely length of ICU stay is an important one, length of 
hospital stay certainly’ (P01, mother, non-bereaved, FiSh phase 
1).
‘Reduce the stay in ICU, would probably be the main one’ (P08, 
mother, non-bereaved, Fever phase 1).
Reduce need/
time spent on 
treatments or 
mechanical support
‘The length of time that he was sedated, which was as a result 
of the length of time that he needed mechanical breathing and 
things like that’ (P7, father, non-bereaved, FiSh phase 1).
‘The fewer machines that were operating with her. I mean we’d 
go from having 12 machines running or 12 syringes going in 
one shape or form. When the syringes got removed and they’d 
have six or four, you knew things were improving’ (P39, mother, 
non-bereaved, FiSh phase 2).
‘Less reliance on, um, life support equipment so, you know, 
more breathing on his own and not having to be on dialysis or, 
um, er, um, and him not having, not having to be, er, as heavily 
sedated as well’ (P08, mother, non-bereaved, Fever phase 1).
‘How quickly they're able to come off intubation’ (P53, father, 
non-bereaved, Fever phase 2).
Survival ‘Well, yeah, obviously survival should be at the top ‘cause that’s 
the, that’s the big one, isn’t it?’ (P08, mother, non-bereaved, 
Fever phase 1).
‘Survival is the main, it is the main thing’ (P78, mother, non-
bereaved Fever phase 2).
FiSh, Fluids in Shock.
resulTs
sample
We interviewed 85 parents (82 via telephone, 3 face to face), 
including 41 (37 mothers, 4 fathers) from the FiSh study and 44 
(33 mothers, 11 fathers) from the Fever study (figure 1). Only 
the researchers and participants were present. Fourteen parents 
were bereaved (13 from phase 1 studies and 1 from phase 2). 
We reached data saturation point16 17 at 21 (FiSh) and 25 (Fever) 
interviews in phase 1 and 20 (FiSh) and 19 (Fever) interviews 
in phase 2. Due to the different recruitment designs, parents in 
phase 1 studies were interviewed at a later time point after their 
child’s hospital admission than parents in phase 2 studies (see 
figure 1). Interviews took between 30 min and 55 min.
Outcomes of importance to parents of children with severe 
infection
Many outcomes discussed by parents during interviews mapped 
closely to outcomes identified in the literature review. Parents 
often prioritised multiple outcomes (eg, in FiSh phase 1, an 
average of six outcomes, and seven outcomes in phase 2).
Online table 2 (S3) shows outcomes identified in the analysis 
of FiSh and Fever interview transcripts. Outcomes are ranked in 
order of importance, defined as how many parents mentioned a 
particular outcome when asked directly which indicators were 
most important to them.
Parents did not always view treatment outcomes for severe 
infection as a set of independent constructs. Many described 
important indicators of improvement as lying on a continuum, or 
‘gradient of seriousness’ (P6, mother, non-bereaved, FiSh phase 
1). Initially looking for ‘the worst [outcome] and then… you sort 
of progressively aim towards the sort of next hurdle to get over’ 
(P10, mother, non-bereaved, FiSh phase 1).
The most commonly prioritised outcomes are presented with 
illustrative quotations in table 2.
Improvement in organ and physiological function
Thirty-eight parents (38/85, 45%) described the importance of 
noticeable improvements in their child’s organ functioning and 
core physiological parameters as short-term treatment outcomes. 
These included heart rate, temperature, dehydration, blood 
pressure and respiratory rate.
Looking and behaving like normal self
The concept of a general, overall feeling of return to health 
or normality was referred to by 33/85 (40%) parents. Parents 
described this as an improvement in their child's appearance and 
temperament. For those with sepsis, this included a reduction 
in the magnitude of swelling and skin discolouration. Improve-
ments in child temperament included references to behaviour 
and mood, including increased alertness and decreased irrita-
bility. These outcomes were linked to improvement in other 
core functions of life, including ‘feeding’ (P49, mother, non-be-
reaved, Fever phase 2), ‘talking’ (P19, mother, non-bereaved, 
FiSh phase 2) and ‘walking’ (P20, mother, non-bereaved, FiSh 
phase 1). Together, improvement in these symptoms was taken 
as an important indicator to parents that their child was recov-
ering and on the road to ‘looking more like herself’ (P13, mother, 
non-bereaved, FiSh phase 1).
Long-term health and development
Parents of recovered children (22/71, 31%) described how 
their child's health status following hospital discharge was an 
important indicator of treatment efficacy. Prioritised outcomes 
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Table 3 Reasons why survival had not been initially prioritised by 
parents
Theme Illustrative quote
Death was not 
considered as an 
outcome
‘I wouldn't have necessarily connected the two, that, um, 
that fever could be so, um, um, so linked to, to something 
so, you know, grave but yeah, um, I guess anything can 
happen, can't, can't it?’ (P73, interview, father, Fever phase 
2).
Don’t want to think of 
death as a possibility
‘It’s just something that you don't, you don't let enter your 
mind. So on reflection, when you're thinking back, you 
don't think of it. I can see that is, er, should be number one 
on the list, definitely’
(P53, interview, father, Fever phase 2).
Because child survived 
so death not considered
‘I think because, you know, she has survived it all through, 
that sort of goes to the back of your mind again, you 
know. You sort of don't think that, you think of oh what… 
but now, you know, now you think about it, you just, yeah, 
you don't think of that. I don't know, it's strange’ (P78, 
interview, mother, Fever phase 2).
Not an option – my 
child was going to 
survive
‘“There’s no option. I’ve lost a nephew, erm, five or 
six years ago, so, obviously, going into hospital and having 
them on the machines was, er… like brought back lots of 
memories, when they’re in intensive care, there’s only two 
ways out of it. You either don’t come out or you come out, 
so like I said to my wife, we’re definitely getting them out, 
or my son, because he was the only one ill at that time. 
(P55, interview, father, Fever phase 2).
Assured no risk of death ‘As soon as we got there, they said, we treat this all the 
time, she’ll be fine. So I didn’t really ever think at that 
point that she wasn’t going to survive…’ (P79, interview, 
mother, Fever phase 2).
included global development and functioning and quality of life. 
Health status was almost always spoken of in terms of the overall 
impact it had on their children’s lives and future experiences (eg, 
the impact of limb amputation). These outcomes featured more 
strongly for parents in the phase 1 FiSh and Fever studies. Only 
one phase 2 study participant indirectly referred to long-term 
effects. This suggests that priorities may evolve with the passage 
of time after a severe illness.
Reduced need/time spent on treatments and mechanical support
A reduction in the number of machines supporting their child, 
including duration of or need for mechanical support was 
described (21/85 parents, 25%) as an important short term 
outcome. This included time on machines (eg, ventilator and 
extracorporeal membrane oxygenation ECMO) and medications 
(eg, morphine).
Length of hospital stay
Seventeen parents (17/85, 20%) discussed length of stay in 
hospital as an important outcome to measure. Six parents (three 
in FiSh, three in Fever) prioritised length of intensive care stay.
survival
Survival was often prioritised by bereaved parents over all other 
outcomes yet was rarely described by parents of recovered 
children in FiSh and phase 1 of Fever. We amended the Fever 
phase 2 topic guide to explore all parents’ views on survival 
as an outcome after they had prioritised outcomes. Following 
prompting, an additional seven parents described survival as 
the most important outcome measure for the proposed RCT 
and future-related trials. Reasons why they had not initially 
mentioned survival included death either not being something 
they had wished to consider or had not considered as their child 
had survived (see table 3). Others had not perceived their child’s 
condition to be life threatening (eg, bronchiolitis).
DIsCussIOn
Our findings provide new insight into parent-prioritised 
outcomes for paediatric emergency medicine or intensive care 
trials investigating treatments for severe infection. In addition 
to survival, parents-prioritised short-term outcomes include: 
organ and physiological functioning; their child looking and/or 
behaving more like their normal self; and length of time on treat-
ments or mechanical support. Longer term prioritised outcomes 
included physical and developmental effects of illness on the 
child.
Consistent with outcomes used in previous trials in this condi-
tion,23–25 parents prioritised improvements in their child’s organ 
and physiological functioning as an indicator of treatment effi-
cacy and recovery. Specifically, parents favoured the alleviation 
of core infection-associated symptomatology, such as heart rate, 
temperature and respiratory rate, increase in blood pressure and 
hydration. Parents frequently referred to their observation of 
monitoring displays and treatments their child received. Linked 
to these outcomes was time to liberation from therapeutic treat-
ments and machines, particularly mechanical ventilation. These 
outcomes were important, as a reduction in their number and 
required usage (eg, time) was viewed as an indication that their 
child was getting better.
The ideal outcome measure in septic shock has been described 
as ‘patient centred, easily measured, and clinically important’,6 
while longer term outcomes are often not prioritised due to 
the practical and financial costs of collecting such data. If trial 
findings are to be impactful in ensuring patient centred health-
care26 27 and influencing policy and practice, then they must 
be relevant and important to patients and families.11 28 Long-
term effects of severe infection, such as physical and develop-
mental consequences, and the short-term outcome of ‘looking 
and behaving more like normal self ’ are not easily measured 
and would rely on parent reports. Nevertheless, this should not 
preclude their consideration or inclusion. Indeed, ‘looking and 
behaving more like normal self ’ was the second most commonly 
prioritised outcome across both studies. To our knowledge, 
there is no validated tool for this outcome. Scales such as the 
Pediatric Overall Performance Category,15 Children’s Critical 
illness Impact Scale29 and Functional Status Score30 could help 
measure some of the functional morbidity and behavioural 
outcomes described. However, they do not capture parents’ 
perspectives on outcomes observed during their child’s PICU 
stay. Further work is needed to define and develop this parent 
prioritised outcome measure.
Survival was prioritised by bereaved parents over all other 
outcomes. However, in many interviews with non-bereaved 
parents, survival was only prioritised after specific prompting. 
Our findings showed that parents had either not perceived their 
child’s life to be at risk, had high expectations of healthcare 
treatments or had not wished to consider the death of their child 
as a possible outcome. This suggests that some parents either did 
not fully comprehend the severity of their child’s illness,31 or 
they had developed adaptive coping behaviours to seek agency 
over the stressful situation by not considering death as a possi-
bility.32 33 However, as mortality rates related to severe infec-
tion are declining in most affluent countries, morbidity-related 
outcomes may be the most appropriate focus for future trials 
investigating severe childhood infections.6 34
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Interestingly, the point at which parents were asked about 
outcomes in the course of their child’s illness appeared to influ-
ence prioritisation. This suggests the need for the development 
of a core outcome set to include patients/family members with a 
range of relevant experiences for that condition and to include 
participants at different time points in the course of their, or 
their child’s, illness. This list of parent-centred outcomes can be 
used in future core outcomes set consensus work (see online S3 
table 2) involving all key stakeholders (eg, clinicians, parents and 
children). Consensus methodology could also be used to iden-
tify the optimal duration of follow-up in these studies, including 
which outcomes to measure at short-term and longer term time 
points.
strengths, limitations and future implications
Our findings contribute to an important and under-researched 
area and demonstrate the value of using qualitative methods to 
explore parents’ perspectives on outcome measures. Synthesis 
of study findings was strengthened by harmonised study 
designs, topics guides and processes, which were developed and 
conducted by the same expert team. Recruitment in each phase 
was conducted until data saturation was reached,16 17 and both 
bereaved and non-bereaved parents with varying experience 
of their child being treated for severe infection were included, 
providing new insight into how views on outcomes may change 
with illness severity and trajectory. As the majority of FiSh and 
Fever participants were infants (eg, in Fever 64% were <1 year 
old), our insight into important outcomes for paediatric septic 
shock is limited to the views of parents. Future research is 
required to explore children’s views on important outcomes in 
emergency and critical care trials.
The list of outcomes compiled from the FiSh literature review 
was presented to parents in the phase 1 studies. Use of a list may 
have influenced their views on outcomes. Nevertheless, common 
themes were identified within and across phases of FiSh and 
Fever studies and similarities between suggested outcomes and 
the predefined set were evident. Finally, more interviews were 
conducted with phase 1 parents (n=46) compared with phase 2 
parents (n=39), which may have biased the order of combined 
outcomes towards phase 1 parents’ priorities.
COnClusIOns
Our findings provide insight into short-term and long-term 
outcomes prioritised by parents to inform the design of future 
trials investigating treatments for paediatric suspected infection 
as well as core outcome set development work. In addition to 
survival, parents prioritised organ and physiological functioning 
their child looking and/or behaving more like their normal self; 
length of time on treatments or mechanical support, and long 
term and effects on child development.
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